Liver toxicity side effects with high-dose AAV

The barrier of liver toxicity side effects with high-dose AAV vectors remains firmly in place.
Sales of the gene therapy for Duchenne muscular dystrophy, “ELEVIDYS”, have resumed in the United States for ambulatory children.
https://miyata-bio.net/column/0000496/